Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder.

Article Details

Citation
Copy to clipboard

Nogovitsina OR, Levitina EV

Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder.

Neurosci Behav Physiol. 2007 Mar;37(3):199-202.

PubMed ID
17294093 [ View in PubMed
]
Abstract

The prevalence of attention deficit hyperactivity disorder (ADHD) in young schoolchildren in Nefteyugansk (Khanty-Mansiiskii Autonomous Region) was found to be 8%, with rates of 13% amongst boys and 3% amongst girls. Clinical investigation of a cohort of 122 children aged 6-11 years identified risk factors for the formation of ADHD as perinatal CNS injuries, inherited predisposition, and unfavorable social-psychological influences. Neuropsychological, neurophysiological (electroencephalography), and biochemical studies identified minor neurological abnormalities, some characteristic features of the motor and emotional spheres, and changes in higher mental functions. In addition, biochemical changes consisting of decreases in plasma and erythrocyte magnesium levels and decreases in Mg(2+)-ATPase activity were identified. Treatment with MAGNE-B(6) allowed correction of many of these changes.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
Magnesium acetateSodium/potassium-transporting ATPase subunit alpha-1ProteinHumans
Unknown
Not AvailableDetails
Magnesium cationSodium/potassium-transporting ATPase subunit alpha-1ProteinHumans
Unknown
Not AvailableDetails
Magnesium lactateSodium/potassium-transporting ATPase subunit alpha-1ProteinHumans
Unknown
Not AvailableDetails
Magnesium levulinateSodium/potassium-transporting ATPase subunit alpha-1ProteinHumans
Unknown
Not AvailableDetails